Cardinal Enterprise Value Over E B I T D A from 2010 to 2024
| CAH Stock | USD 122.63 0.19 0.16% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 12.08806876 | Current Value 7.95468278 | Quarterly Volatility 29.15515112 |
Check Cardinal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardinal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 360.6 M, Interest Expense of 48.5 M or Selling General Administrative of 5.2 B, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.004 or PTB Ratio of 1.58. Cardinal financial statements analysis is a perfect complement when working with Cardinal Health Valuation or Volatility modules.
Cardinal | Enterprise Value Over E B I T D A |
Latest Cardinal Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Cardinal Health over the last few years. It is Cardinal Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Cardinal Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 17.55 | |
| Coefficient Of Variation | 166.14 | |
| Mean Deviation | 14.07 | |
| Median | 10.25 | |
| Standard Deviation | 29.16 | |
| Sample Variance | 850.02 | |
| Range | 128 | |
| R-Value | 0.24 | |
| Mean Square Error | 861.66 | |
| R-Squared | 0.06 | |
| Significance | 0.38 | |
| Slope | 1.58 | |
| Total Sum of Squares | 11,900 |
Cardinal Enterprise Value Over E B I T D A History
About Cardinal Health Financial Statements
Investors use fundamental indicators, such as Cardinal Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Cardinal Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 12.09 | 7.95 |
Currently Active Assets on Macroaxis
When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:Check out the analysis of Cardinal Health Correlation against competitors. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 48.135 | Dividend Share 2.012 | Earnings Share 5.21 | Revenue Per Share 921.782 | Quarterly Revenue Growth (0.04) |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.